LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Living Subacromial Bursa-Derived Cells for Rotator Cuff Repair
Large Joints and Extremities

Living Subacromial Bursa-Derived Cells for Rotator Cuff Repair

December 1, 2020 1 min read Premium comments

Advertisement

Living Subacromial Bursa-Derived Cells for Rotator Cuff Repair
Source: Unsplash and CDC
#rotatorcufftear#rotatorcuffrepairSecondary#subacromialbursaderivedcells

High proliferation of subacromial bursa-derived cells is still possible in most people with a rotator cuff tear, according to new data.

In the study, “Subacromial Bursa-Derived Cells Demonstrate High Proliferation Potential Regardless of Patient Demographics and Rotator Cuff Tear Characteristics,” published in the November 1, 2020 issue of the journal Arthroscopy, the researchers set out to see if patient demographics and rotator cuff tear characteristics had any effect on the proliferation of subacromial bursa-derived cells.

They collected data on patients undergoing arthroscopic rotator cuff repair between December 2017 and February 2019, including basic demographic information and medical and surgical history.

In addition, subacromial bursa was harvested from over the rotator cuff tendon. After a three-week incubation period, the researchers counted nucleated subacromial burse-derived cells. They also conducted a fluorescence-activated cell sorting analysis to confirm the presence of mesenchymal stem cell specific surface markers.

The researchers used preoperative radiographs and magnetic resonance imaging to evaluate acromiohumeral distance, severity of cuff tear arthropathy, and rotator cuff characteristics.

Overall, 73 patients were included in the study. The mean age was 57.2±8.5 years. The researchers found no significant difference in cellular proliferation of subacromial bursa-derived cells regardless of age, sex, body mass index, smoking status, and presence of systemic comorbidities (p > .05, respectively).

They also found no difference in cellular proliferation of subacromial bursa-derived cells regardless of rotator cuff tear characteristics such as size, tendon retraction, fatty infiltration, and muscle atrophy, or severity of cuff tear arthropathy (p > .05). Analysis showed a high positive rate of mesenchymal stem cell specific surface markers.

The researchers wrote, “Subacromial bursa consistently demonstrated a high cellular proliferation potential regardless of patient demographics, rotator cuff tear characteristics, and severity of glenohumeral joint degeneration.”

They added, “These findings may alleviate concerns that subacromial bursa might lose cellular proliferation potential when being used for biologic augmentation in massive and degenerated rotator cuff tears, this assisting in predicting tendon healing and facilitating surgical decision-making.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy